Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy. Observational, Descriptive, Open-label, Multi-centric, Non-randomized Study

Trial Profile

Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy. Observational, Descriptive, Open-label, Multi-centric, Non-randomized Study

Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Aug 2017

At a glance

  • Drugs Vigabatrin (Primary)
  • Indications Infantile spasms; Partial epilepsies
  • Focus Therapeutic Use
  • Acronyms SoluWest
  • Sponsors Targeon
  • Most Recent Events

    • 25 Aug 2015 Endpoints and treatment details modified as per protocol amendment reported by ClinicalTrials.gov.
    • 25 Aug 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Dec 2016, as reported by ClinicalTrials.gov.
    • 25 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top